Diagnostic efficiency of biological markers in blood serum on prostate cancer: A comparison of four different markers and 12 different methods

References

• Vihko P, Sajanti E, Janne O, Peltonen L, Vihko R. Serum prostate‐specific acid phosphatase: development and validation of a specific radioimmunoassay. Clin Chem 1978; 24: 1915–9
   PubMedGoogle Scholar
• Killian C S, Vargas F P, Lee C L, Wang M C, Murphy G P, Chu T M. Quantitative counter‐immunoelectrophoresis assay for prostatic acid phosphatase. Invest Urol 1980; 18: 219–24
   PubMedGoogle Scholar
• de Vries G P, Sanders G TB. Development and clinical evaluation of two immunoassays for prostatic acid phosphatase in serum. Am J Clin Pathol 1982; 78: 189–95
   PubMedGoogle Scholar
• Griffiths J, Rippe D F, Panfili P R. Comparison of enzyme‐linked immunosorbent assay and radioimmunoassay for prostate‐specific acid phosphatase in prostatic disease. Clin Chem 1982; 28: 183–6
   PubMed Web of Science ®Google Scholar
• Wirth M P, Gomes de Oliveira J, Frohmüller H GW. Monoclonal antibody‐based radioimmunoassay compared with conventional enzyme immunoassay in the detection of prostatic acid phosphatase. Eur Urol 1984; 10: 326–30
   PubMedGoogle Scholar
• Killian C S, Vargas F P, Slack N H, Murphy G P, Chu T M. Prostate‐specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancer. Ann NY Acad Sci 1982; 390: 122–32
   PubMed Web of Science ®Google Scholar
• Wang M C, Valenzuela L A, Murphy G P, Chu T M. Purification of a human prostate specific antigen. Invest Urol 1979; 17: 159–63
   PubMedGoogle Scholar
• Kuriyama M, Wang M C, Papsidero L D, et al. Quantitation of prostate‐specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980; 40: 4658–62
   PubMed Web of Science ®Google Scholar
• Liedtke R J, Batjer J D. Measurement of prostate‐specific antigen by radioimmunoassay. Clin Chem 1984; 30: 649–52
   PubMed Web of Science ®Google Scholar
• Feld R D, Witte D L. Presence of preatine kinase BB isoenzyme in some patients with prostate carcinoma. Clin Chem 1977; 23: 1930–2
   PubMed Web of Science ®Google Scholar
• Silverman L M, Dermer G B, Zweig M H, Van Steirteghem A C, TØkes Z A. Creatine kinase BB: a new tumor‐associated marker. Clin Chem 1979; 25: 1432–5
   PubMed Web of Science ®Google Scholar
• Fair W R, Heston W DW, Kadmon D, et al. Prostatic cancer, acid phosphatase, creatine kinase‐BB and race: a prospective study. J Urol 1982; 128: 735–8
   PubMedGoogle Scholar
• Holmgren J, Lindholm L, Persson B, et al. Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Brit Med J 1984; 288: 1479–82
   PubMed Web of Science ®Google Scholar
• TNM‐classification of malign tumors 1978. Prostate, M H Harmer. International Union Against Cancer, Geneva 1978; 118–21
   Google Scholar
• Jacobsson K. The determination of tartrate‐inhibited phosphatase in serum. Scand J Clin Lab Invest 1960; 12: 367–80
   PubMed Web of Science ®Google Scholar
• Hillman G. Fortlaufende photometrische messung der sauren prostataphosphatase‐aktivität. J Clin Chem Clin Biochem 1971; 9: 273–4
   Google Scholar
• Nustad K, Johansen L, Ugelstad I, Ellingsen T, Berge A. Hydrophilic monodisperse particles as solid‐phase material in immunoassays: comparison of shell‐and‐core particles with compact particles. Eur Surg Res 1984; 16(Suppl. 2)80–7
   PubMedGoogle Scholar
• Skinningsrud A, Nustad K. Prostatic acid phosphatase, purification and iodination using Iodogen. Clin Chim Acta 1982; 120: 29–40
   PubMedGoogle Scholar
• Urdal P, Kierulf P. Sensitive and specific radioimmunoassay for creatine kinase BB isoenzyme in serum, with use of an autoantibody. Clin Chem 1981; 27: 83–7
   PubMed Web of Science ®Google Scholar
• Saini M S, Van Etten R L. A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate. Prostate 1981; 2: 359–68
   PubMedGoogle Scholar
• Seiler V D, Nagel D, Tritschler W, Looser S. Saure Phosphatase im serum (substrat: α‐naphthylphosphat): referenzwerte und diagnostische aussage. J Clin Chem Clin Biochem 1983; 21: 519–25
   PubMedGoogle Scholar
• Foti A G, Cooper J F, Herschman H, Malvaez R R. Detection of prostatic cancer by solid‐phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med 1977; 297: 1357–61
   PubMed Web of Science ®Google Scholar
• Griffiths J. Prostate‐specific acid phosphatase: re‐evaluation of radioimmunoassay in diagnosing prostatic disease. Clin Chem 1980; 26: 433–6
   PubMed Web of Science ®Google Scholar
• Vihko P, Kostama A, Jänne O, Sajanti E, Vihko R. Rapid radioimmunoassay for prostate‐specific acid phosphatase in human serum. Clin Chem 1980; 26: 1544–7
   PubMed Web of Science ®Google Scholar
• Huber P R, Scholer A, Under E, Hagmaier V, Vogt H, Christen P, Eppenberger U, Rutishauser G. Measurement of prostatic acid phosphatase in serum and bone marrow: radioimmunoassay and enzymic measurement compared. Clin Chem 1982; 28: 2044–50
   PubMedGoogle Scholar
• Goldenberg S L, Silver H KB, Sullivan L D, Morse M, Archibald E L. A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase. Cancer 1982; 50: 1847–51
   PubMedGoogle Scholar
• Bauer H W, Schmidt E. Wertigkeit eines immunenzymatischen assays für die prostataspezifische saure phosphatase (PAP) (E.C. 3.1.3.2.) beim prostatakarzinom. Urologe 1983; 22: 267–71
   Google Scholar
• Vihko P, Kontturi M, Lukkarinen O, Ervasti J, Vihko R. Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radio‐immunologic measurements of serum acid phosphatases compared. Cancer 1985; 56: 173–7
   PubMed Web of Science ®Google Scholar
• de Vries G P, Stout J PJ, Sanders G TB. Evaluation of an enzyme‐linked immunosorbent assay for prostatic acid phosphatase. Clin Chim Acta 1984; 140: 279–88
   PubMedGoogle Scholar
• Carson J L, Eisenberg J M, Shaw L M, Kundel H L, Soper K A. Diagnostic accuracy of four assays of prostatic acid phosphatase. Comparison using receiver operating characteristic curve analysis. JAMA 1985; 253: 665–9
   PubMed Web of Science ®Google Scholar
• Henderson A R, Nealon D A. Enzyme measurements by mass: an interim review of the clinical efficacy of some mass measurements of prostatic acid phosphatase and the isoenzymes of creatine kinase. Clin Chim Acta 1981; 115: 9–32
   PubMedGoogle Scholar
• Zweig M H, Robertsen E A. Why we need better test evaluations. Clin Chem 1982; 28: 1272–6
   PubMed Web of Science ®Google Scholar